Nolvadex

NOLVADEX BY BELIGAS PHARMACEUTICALS

Tablets

DRUG COMPOSITION

1 tablet contains:
- active substance: tamoxifen citrate 10 mg;
- auxiliary substances:

DRUG DESCRIPTION

PHARMACEUTICAL FORM

Tablets.

PHARMACEUTICAL GROUP AND ATC CODE

Selective Estrogen Receptor Modulator.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: 5 Days
Routes of administration: by mouth
Dosage forms: (Men): 20-120 mg/day; (Women): -
Acne: no
Water retention: no
High blood pressure: no
Hepatotoxicity: very low
Aromatase: no
Decreased HPTA function (own testosterone production): none
Anabolic activity: Not a steroid
Androgenic activity: Not a steroid
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

10 mg tablets.
50 tablets in sachets.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

March 2020

NAME AND ADDRESS OF THE MANUFACTURER

Beligas Pharmaceuticals
Belgium